Zobrazeno 1 - 10
of 30 464
pro vyhledávání: '"J. YOSHIDA"'
Publikováno v:
Gynecologic Oncology Reports, Vol 50, Iss , Pp 101310- (2023)
The Society of Gynecologic Oncology (SGO) Journal Club webinar series is an open forum that invites national experts to discuss the literature pertaining to important topics in the management of gynecologic cancers. On August 14th, 2023, SGO hosted a
Externí odkaz:
https://doaj.org/article/28fe625836734e008f8d98601e5d24bb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Takahashi, Yusuke1 (AUTHOR), Ashikari, Yosuke1 (AUTHOR), Takumi, Masahiro1 (AUTHOR), Shimizu, Yutaka1 (AUTHOR), Jiang, Yiyuan1 (AUTHOR), Higuma, Ryosuke1 (AUTHOR), Ishikawa, Susumu1 (AUTHOR), Sakaue, Hodaka1 (AUTHOR), Shite, Ibuki1 (AUTHOR), Maekawa, Kei1 (AUTHOR), Aizawa, Yoko1 (AUTHOR), Yamashita, Hiroki1 (AUTHOR), Yonekura, Yuya1 (AUTHOR), Colella, Marco2 (AUTHOR), Luisi, Renzo2 (AUTHOR), Takegawa, Toshihiro1 (AUTHOR), Fujita, Chiemi1 (AUTHOR), Nagaki, Aiichiro1 (AUTHOR) anagaki@sbchem.kyoto‐u.ac.jp
Publikováno v:
European Journal of Organic Chemistry. 2/7/2020, Vol. 2020 Issue 5, p618-622. 5p.
Autor:
Mary Kathryn Abel, Amy M. Shui, Michelle Melisko, A. Jo Chien, Emi J. Yoshida, Elizabeth M. Lancaster, Laura Van ‘T Veer, Laura J. Esserman, Rita A. Mukhtar
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract When molecular testing classifies breast tumors as low risk but clinical risk is high, the optimal management strategy is unknown. One group of patients who may be more likely to have such discordant risk are those with invasive lobular carc
Externí odkaz:
https://doaj.org/article/b88c275529fe4c4da1b6cfc8c63c7d7e
Autor:
Go J. Yoshida, Hideyuki Saya
Publikováno v:
Regenerative Therapy, Vol 17, Iss , Pp 38-50 (2021)
Intratumoral heterogeneity is tightly associated with the failure of anticancer treatment modalities including conventional chemotherapy, radiation therapy, and molecularly targeted therapy. Such heterogeneity is generated in an evolutionary manner n
Externí odkaz:
https://doaj.org/article/f08a332dd0dd4b1dad23946d25a5fa6d
Autor:
Nagaki, Aiichiro1 (AUTHOR) anagaki@sbchem.kyoto-u.ac.jp, Jiang, Yiyuan1 (AUTHOR), Yamashita, Hiroki1 (AUTHOR), Takabayashi, Naoshi1 (AUTHOR), Takahashi, Yusuke1 (AUTHOR), Yoshida, Jun-ichi2 (AUTHOR) j-yoshida@jim.suzuka-ct.ac.jp
Publikováno v:
Chemical Engineering & Technology. Oct2019, Vol. 42 Issue 10, p2113-2118. 6p.
Autor:
Go J. Yoshida
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-15 (2020)
Abstract Accumulating evidence indicates that intratumoral heterogeneity contributes to the development of resistance to anticancer therapeutics. Fibroblasts, which are components of the paraneoplastic stroma, play a crucial role in the wound-healing
Externí odkaz:
https://doaj.org/article/0017a1e14310457da4e6814671dfa090
Autor:
Go J. Yoshida
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Abstract Patient-derived tumor xenografts (PDXs), in which tumor fragments surgically dissected from cancer patients are directly transplanted into immunodeficient mice, have emerged as a useful model for translational research aimed at facilitating
Externí odkaz:
https://doaj.org/article/8013db859f2c4d9eb61da5198872f792
Autor:
Shibuya, Akito1 (AUTHOR), Nokami, Toshiki1,2 (AUTHOR) tnokami@tottori-u.ac.jp
Publikováno v:
Chemical Record. Sep2021, Vol. 21 Issue 9, p2389-2396. 8p.
Autor:
Y. Ebara, J. Yoshida, H. Tsutsui, S. Nakajima, S. Hara, T. Tsurudome, T. Miyashita, Y. Kumata
Publikováno v:
IEEE Transactions on Applied Superconductivity. 33:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57ca203305b5bb03fb6c2e67d5645892
https://doi.org/10.1109/tasc.2023.3245563
https://doi.org/10.1109/tasc.2023.3245563